← All Viemed Healthcare, INC filings

Viemed Healthcare, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
VMD
Viemed Healthcare, INC
DEF: Viemed Healthcare 2026 Proxy and Equity Plan Update
Viemed Healthcare, Inc. has issued its 2026 proxy statement, seeking shareholder approval for director elections, auditor reappointment, and an increase in shares for its 2024 Long Term Incentive Plan.
NASDAQ
VMD
Viemed Healthcare, INC
DEFA14A: Viemed Healthcare Sets Date for 2025 Annual General and Special Meeting
Viemed Healthcare will hold its annual general and special meeting of shareholders on June 5, 2025, to discuss key corporate matters including financial statements, director elections, auditor appointment, and executive compensation.
NASDAQ
VMD
Viemed Healthcare, INC
DEF: Viemed Healthcare Seeks Shareholder Approval for Amended Incentive Plan, Executive Compensation, and Auditor Re-Appointment at 2025 Annual Meeting
Viemed Healthcare is holding its annual general and special meeting on June 5, 2025, to vote on key proposals including amendments to the long-term incentive plan, executive compensation, and the re-appointment of Ernst & Young LLP as auditors.
NASDAQ
VMD
Viemed Healthcare, INC
DEF 14A: Viemed Healthcare Sets Date for 2024 Annual General and Special Meeting
Viemed Healthcare will hold its 2024 annual general and special meeting on June 6, 2024, to discuss financial statements, elect directors, appoint auditors, and ratify the 2024 Long Term Incentive Plan.
NASDAQ
VMD
Viemed Healthcare, INC
DEFA14A: Viemed Healthcare Sets Date for Annual General and Special Meeting, Outlines Key Proposals
Viemed Healthcare will hold its annual general and special meeting on June 6, 2024, to discuss audited financials, elect directors, appoint auditors, and ratify the 2024 Long Term Incentive Plan.